Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond P Goodrich

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Transfusion|March 13, 2018
Ignorance is not blissRaymond P Goodrich
Transfusion|November 13, 2012
In reply to: "Is the SCID mouse model applicable to human acute lung injury?"Raymond P Goodrich
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 19, 2018
Special considerations for the use of pathogen reduced blood components in pediatric patients: An overviewRaymond P Goodrich, Jerard Segatchian
Biologicals : Journal of the International Association of Biological Standardization|January 23, 2010
Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood productsRaymond P Goodrich, Suzann Doane, Heather L Reddy
Pathogens (Basel, Switzerland)|July 29, 2023
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction TechnologiesMarcia Cardoso, Izabela Ragan, Lindsay Hartson, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 18, 2018
Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processesAicha Bah, Marcia Cardoso, Jerard Seghatchian, et al.
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 15, 2011
Improving blood safety and patient outcomes with pathogen reduction technologyRaymond P Goodrich, Anna Ettinger, Piotr M Radziwon, et al.
Transfusion|August 22, 2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentratesDaniel R Ambruso, Gail Thurman, Susanne Marschner, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 29, 2006
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trendsRaymond P Goodrich, Richard A Edrich, Junzhi Li, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Transfusion|March 13, 2018
Ignorance is not blissRaymond P Goodrich
Transfusion|November 13, 2012
In reply to: "Is the SCID mouse model applicable to human acute lung injury?"Raymond P Goodrich
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 19, 2018
Special considerations for the use of pathogen reduced blood components in pediatric patients: An overviewRaymond P Goodrich, Jerard Segatchian
Biologicals : Journal of the International Association of Biological Standardization|January 23, 2010
Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood productsRaymond P Goodrich, Suzann Doane, Heather L Reddy
Pathogens (Basel, Switzerland)|July 29, 2023
Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction TechnologiesMarcia Cardoso, Izabela Ragan, Lindsay Hartson, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 18, 2018
Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processesAicha Bah, Marcia Cardoso, Jerard Seghatchian, et al.
Transfusion|April 9, 2010
Defining "adequate" pathogen reduction performance for transfused blood componentsRaymond P Goodrich, Brian Custer, Shawn Keil, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 15, 2011
Improving blood safety and patient outcomes with pathogen reduction technologyRaymond P Goodrich, Anna Ettinger, Piotr M Radziwon, et al.
Transfusion|August 22, 2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentratesDaniel R Ambruso, Gail Thurman, Susanne Marschner, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 29, 2006
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trendsRaymond P Goodrich, Richard A Edrich, Junzhi Li, et al.
Pageof 7